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Background: Cases of patients with primary intraocular lymphoma (PIOL) were retrospectively analyzed to describe
the longitudinal intra-retinal morphological changes in PIOL as visualized on images obtained by spectral domain
optical coherence tomography (SD-OCT).
Results: In a retrospective case series, Heidelberg Spectralis SD-OCT images obtained in the longitudinal evaluation
of patients with biopsy-proven PIOL were analyzed and assessed. The images were graded for the presence of
macular edema (ME), pigment epithelial detachment (PED), subretinal fluid (SRF), and hyperreflective signals.
SD-OCT scans of five eyes from five patients were assessed. Patients showed signs of inflammation, such as ME and
SRF, which were resolved with treatments in some cases. Hyperreflective signals were found in all eyes in the form
of nodules or bands across the retina, with the highest frequency of appearance in the ganglion cell layer, inner
plexiform layer, photoreceptor layer, and retinal pigment epithelium; such signals increased with the progression of
PIOL.
Conclusion: SD-OCT may be employed to monitor the progression of PIOL. Hyperreflective signals on OCT may
correspond with increase in disease activities, along with other findings such as ME, PED, and SRF.
Keywords: Spectral domain optical coherence tomography (SD-OCT), Primary intraocular lymphoma, Primary retinal
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Primary intraocular lymphoma (PIOL) is a subset of pri-
mary central nervous system lymphoma (PCNSL). It is a
rare non-Hodgkin's lymphoma that usually involves the
retina and vitreous, mainly consisting of large B-cells.
PIOL represents about 1% of non-Hodgkin's lymph-
omas, 1% of intracranial tumors, and less than 1% of
intraocular tumors [1]. It has been reported that 15% to
25% of PCNSL cases involve the eye; these may initially
be present without concurrent central nervous system
(CNS) involvement [2,3].* Correspondence: quan.nguyen@unmc.edu
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in any medium, provided the original work is pPIOL is the most common neoplastic disease that
masquerades chronic posterior uveitis [4]. When mis-
diagnosed as uveitis, patients may initially respond to cor-
ticosteroids, which further contributes to the diagnostic
challenge [2]. PIOL may also manifest in the anterior seg-
ment as keratic precipitates, cells, and flare [5]. The identi-
fication of atypical lymphoid cells in the eye is necessary
to make the diagnosis [6,7].
Assessment of PIOL using ultrasonography, fluores-
cein angiography, indocyanine green angiography, and
optical coherence tomography has been reported with a
common finding of intra- and sub-RPE (retinal pigment
epithelium) infiltrates [2,8]. Additionally, a few case
reports of PIOL have utilized spectral domain optical
coherence tomography (SD-OCT) to capture high-
resolution cross sections of the retina [9-11]. However,
the common patterns of SD-OCT changes in PIOL haveOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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the relative novelty of SD-OCT imaging. To the best of
our knowledge, progression of PIOL utilizing SD-OCT
has been reported in one case report [11]. We herein
report patterns of anatomic changes as visualized by SD-
OCT in five patients of PIOL over a period of 161 ± 61
days.
Methods
An informed written consent that was approved by the
Institutional Review Board of Johns Hopkins University
was obtained from all patients included in the study.
Patients with biopsy-proven PIOL who had been man-
aged by one of the authors (QDN) at the Wilmer Eye
Institute and followed using SD-OCT were included
in the index retrospective case series. Patients either
received systemic high-dose methotrexate (MTX), sys-
temic rituximab (RTX), and/or intravitreal MTX and
RTX.
For each patient, 30° SD-OCT scans of the macula
from three to four visits were analyzed carefully in the
Retinal Imaging Research and Reading Center (RIRRC)
at Wilmer, including scans at the first presentation of
symptoms, a visit before treatment, and a post-treatment
visit when available. The first visit was considered as the
baseline and was labeled Day 0. A senior grader selected
multiple cross sections that were representative of the
retinal changes in each case. These selected sections
were evaluated by two independent graders in the
RIRRC who were informed of the patients' diagnosis but
masked to the visits that were graded. Presence of
hyperreflective signals, macular edema (ME), pigment
epithelial detachment (PED), subretinal fluid (SRF), and
any other abnormalities were assessed. The locations of
hyperreflective signals were marked as being present in
the following layers: nerve fiber layer (NFL), ganglion
cell layer (GCL), inner plexiform layer (IPL), inner nu-
clear layer (INL), outer plexiform layer (OPL), outer nu-
clear layer (ONL), photoreceptor layer (PRL), RPE, and
choroid. Any disagreement between the two graders was
decided by a third senior grader. The TruTrack™ active
eye tracking system in Spectralis SD-OCT allowed for
comparative analysis of the same cross sections between
the visits.Table 1 Demographics of study subjects
Patient Age Gender Study eye Race
1 76 Male OD Caucasi
2 70 Male OS Caucasi
3 73 Male OS Caucasi
4 52 Female OD Caucasi
5 60 Female OS Caucasi
OD, right eye; OS, left eye; Time of observation, number of days between the baselResults and discussion
Results
Five eyes of five patients were included. SD-OCT images
from a total of 16 visits were reviewed, with a mean
duration of 163 ± 61 days between baseline and last
reviewed visit. Patient 5 had recurring disease, and only
the latest recurrence of active disease was reviewed,
since SD-OCT scans were not taken in the previous
visits. The patient demographics and clinical findings are
summarized in Tables 1 and 2, respectively.
Figure 1 summarizes the SD-OCT findings for all
patient visits included in this study. Hyperreflective
signals appeared as nodules or bands, found across
the retina, RPE, and/or choroid. Figures 2,3,4,5,6 cor-
respond to the course of patients 1 to 5, respectively.
Each figure shows the disease progression in one of
the graded SD-OCT images, as well as color fundus
or Optos® ultra-wide-field images from the corre-
sponding visits.
Clinical description of PIOL manifestation
In the following descriptions and corresponding figures,
Day 0 corresponds to the first visit with symptoms and
signs of PIOL in the study eye, with the exception of
patient 5. Patient 5 had recurring PIOL, and Day 0
corresponds to the first visit of the latest recurrence.
Patient 1 initially presented with severe vitreous in-
flammation affecting the vision in the right eye, which
subsided with anti-inflammatory drugs in the follow-up
visits. ME was present throughout the visits. He had had
large B-cell intraocular lymphoma in the left eye in the
past, which had not been documented with SD-OCT.
Repeated evaluations of the CNS during the manifest-
ation in the right eye did not reveal active CNS
lymphoma. The patient was treated with systemic MTX
and RTX. On SD-OCT, hyperreflective signals were
found in the inner and outer retina, as well as RPE. SRF
developed with disease progression (Figure 2).
Patient 2 had a history of PCNSL and presented with
vitreous cells and a large vitreous condensation in the
left eye. During the follow-up visit, sheets of vitreous
cells became more pronounced, which is commonly
observed in intraocular lymphoma [12]. The diagnosis of
PIOL was confirmed by a biopsy of the vitreous obtainedHistopathology Time of observation (days)
an Large B-cell lymphoma 212
an Large B-cell lymphoma 119
an Large B-cell lymphoma 204
an Large B-cell lymphoma 77
an Large B-cell lymphoma 201
ine and last reviewed visit.
Table 2 Clinical findings over the observation period
Patient Slit lamp and fundus examination findings
1 Anterior chamber cells and flare, vitreous cells and debris,
macular edema
2 Vitreous cells and condensation, yellowish
chorioretinal lesions
3 Keratic precipitates, anterior chamber cells and flare,
vitreous cells, yellowish chorioretinal lesions
4 Vitreous cells, macular edema, yellowish chorioretinal lesions
5 Anterior chamber flare, vitreous haze, layered hypopyon
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with MTX and RTX. The patient also has bilateral age-
related macular degeneration (AMD). PED from AMD,
as well as hyperreflective signals in the retina and RPE
were found on SD-OCT (Figure 3).Figure 1 Longitudinal SD-OCT finding. Day 0 corresponds to the baselin
intraocular lymphoma for patient 5. V indicates the date of the diagnostic
and/or rituximab). SD-OCT images taken on the days marked with downwa
positive finding being indicated by a black box.Patient 3 presented with mutton fat keratic precipitates,
anterior chamber cells and flare, and clumps of vitreous
cells in the left eye. Clinical findings and the patient's his-
tory of PCNSL were indicative of PIOL, as confirmed by
vitrectomy. Subretinal infiltrates were followed 5 months
after baseline evaluation. In addition to systemic MTX
and RTX, the patient also received one injection of
intravitreal MTX due to disease progression. SD-OCT ini-
tially revealed few hyperreflective signals in nodular shape,
consistent with infiltrates in the retina and RPE. With
disease progression, RPE disruption and hyperreflective
bands in the retina emerged (Figure 4). The case report of
this patient by Liu et al. has been published [11].
Patient 4 was referred to the Wilmer Eye Institute after
being treated with topical steroids for persistent ME. The
patient had a history of PCNSL. On examination, thee visit for patients 1 to 4 and the first visit of the latest recurrence of
vitrectomy. T indicates the initiation of therapy (systemic methotrexate
rd arrows were graded for ME, PED, SRF, and HS in retinal layers with
Figure 2 Patient 1. (Top) Day 0, there are multiple hyperreflective signals in the inner retina, indicated by the arrowheads. ME is present. The
Optos® wide-angle fundus image shows sheets of cells. (Center) Day 105, examples of hyperreflective signals are pointed by the arrowheads. The
arrowhead on the right points to thickening of the OPL. The arrow indicates hyperreflective signals in OPL. Slight disruption of the RPE is pointed
by the bottom arrowhead. Color fundus shows significant vitritis. (Bottom) Day 212, the arrow points to elevation of RPE due to an accumulation
of SRF. A nodular hyperreflective signal is pointed by the arrowhead. The view of the fundus is clear following vitrectomy.
Figure 3 Patient 2. (Top) Day 0, multiple nodular hyperreflective signals in the outer retina are indicated by the arrowheads. The rightmost
arrowhead points to hyperreflective signals at PRL and RPE level. RPE disruption is present due to drusen. There are sheets of vitreous cells shown
in the Optos® wide-angle image. (Center) Day 77, arrowheads indicate hyperreflective changes at PRL and RPE. Severe vitritis as shown in the left
fundus contributes to the noisy SD-OCT scan. Optos® wide-angle image shows increased vitreous inflammation. (Bottom) Day 119, arrowheads
point to nodular hyperreflective signals that may be lymphomatous infiltrates. The view of the fundus is clearer post-vitrectomy.
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Figure 4 Patient 3. (Top) Day 27, the image appears normal with few abnormal hyperreflective signals that may indicate infiltrates as
indicated by the arrowheads. Optos® wide-angle image shows clear vitreous following vitrectomy. (Center, upper) Day 72, the retina remains
unchanged with a few hyperreflective signals as indicated by the arrowheads. No fundus image was available. (Center, lower) Day 175,
evident hyperreflective signals are pointed by arrowheads. Layers are distorted, and RPE is disrupted as shown by the arrow. Inner segment/
outer segment interface is no longer visible. There are new yellow lesions seen in the Optos® wide-angle image. A creamy lesion in the fovea
is evident. (Bottom) Day 231, an increased amount of hyperreflective signals is found throughout the retina, and the overall reflectivity has
also increased. RPE disruption has developed into pigment epithelial detachment as indicated by the arrow. Hyperreflective foci are found in
the choroid as well. Optos® wide-angle image shows an increased degree of infiltration.
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ing diagnostic vitrectomy which revealed the presence of
lymphomatous cells, systemic MTX and RTX were given.
SD-OCT revealed ME, PED, and hyperreflective signals,
especially notable at the RPE. Number of layers with
hyperreflective dots decreased following vitrectomy
(Figure 5).
Patient 5 had recurrent bilateral biopsy-proven PIOL
and PCNSL for 5 years. Each recurrence had been effect-
ively treated with systemic MTX and RTX. The recur-
rences were marked by keratic precipitates, hypopyon,
vitreous haze, and/or ME. In the latest recurrence, the
patient presented with mild anterior chamber flare and
mild vitreous haze in the left eye. During the follow-up
visits, layered hypopyon was present. The patient was
treated with systemic MTX and RTX. SD-OCT findings
included thickened OPL and hyperreflective signals in
the inner and outer retina, as well as RPE (Figure 6).
Discussion
Advancements in imaging technology in general and
OCT in particular during the past decade have allowed
for non-invasive identification of anatomical changesvery much at the tissue level. In this study, we aimed to
characterize the longitudinal changes in the retina with
PIOL visualized by SD-OCT during the course of the
disease. Previously reported OCT findings in PIOL
include ME, hyperreflective materials at the RPE and
outer retina, RPE disruption, and subretinal deposits
which are similar to the abnormalities found in our
study [8,11]. In particular, SD-OCT images of patient 4
were notably similar to those of the one case reported
by Liang et al. with hyperreflective nodules at the
RPE [10]. Our most common findings are abnormal
hyperreflective signals that appeared as dots, nodules,
and bands, with the highest frequency of appearance
in GCL, IPL, PRL, and RPE as shown in Figure 1.
Although hyperreflectivity in the inner retina was not
discussed in previous OCT studies of PIOL, we iden-
tified hyperreflective signals in the inner retina of all
patients with PIOL, which is most clearly illustrated
in Figure 2. Chan et al. have shown that in murine
models of PIOL, lymphoma cells inoculated in the
vitreous can migrate and gather between RPE and
retina, suggesting that lymphoma cells can be found
across the retina [13].
Figure 5 Patient 4. (Top) Day 0, macular edema with intracystic changes is circled. Arrowheads indicate hyperreflective signals at the PRL and
RPE. The OCT scan was done before vitrectomy; there is significant noise in the scan. Optos® wide-angle image is from Day 14, following
vitrectomy. (Center) Day 19, the arrows indicate intraretinal fluids. Lesions at the PRL and RPE are pointed by the arrowheads. Optos® wide-angle
image from the same day shows stable retina. (Bottom) Day 77, hyperreflective signals at the RPE pointed by the arrowheads have arguably
thickened. Hyperreflective signals are also seen in the inner retina. An arrowhead points to an example in the inner nuclear layer. No changes are
seen in the Optos® wide-angle image from the same day.
Figure 6 Patient 5. Unusually thick OPL is noted by an arrow and hyperreflective signals are indicated with arrowheads. (Top) Day 0, color
fundus photograph is from a visit that took place a month before Day 0; no significant change in the fundus examination was noted in between
the two visits. (Center) Day 63, an increase in hyperreflective signals is seen, which correlates to the increase in disease activity. (Bottom) Day 201,
an increase in hyperreflective signals was noted, which may correlate to a significant increase in disease activity, manifested also by increased
hypopyon, on this visit.
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nals on SD-OCT images of patients with PIOL that
have been reported in the literature, the specific nature
of the hyperreflective material seen within the inner
and outer retina is still to be evaluated, and becomes a
challenge without direct supporting histopathological
evidence. Additionally, hyperreflective signals can be
overestimated when inherent noise and vitreous haze
are present, and careful distinction should be made dur-
ing the grading and evaluating process. Moreover,
hyperreflective foci have been reported in numerous
diseases, such as AMD and diabetic macular edema,
and should be excluded as sources of findings seen in
PIOL patients [14-16]. In the case of patient 3, the
changes in SD-OCT with the progression of PIOL evi-
dently appeared as hyperreflective bands in INL, OPL,
and ONL with corresponding chorioretinal changes seen
in fundus examinations. Patient 5 had an increase in
activity of disease noted in the anterior segment that
corresponded to an increase in hyperreflective lesions
noted in the retina (Figure 6). On the other hand,
patient 2 has bilateral AMD; hyperreflective nodules at
the RPE level may have indicated lymphoma infiltrates
or equally may have been representative of hyper-
reflective lesions that have been reported in intermedi-
ate AMD (Figure 3) [14]. Therefore, hyperreflective
changes in SD-OCT should be interpreted in the
context of clinical findings.
Conclusions
Submacular infiltration of lymphoma cells may be visu-
alized by high-resolution SD-OCT but should be differ-
entiated from noise on a suboptimal quality scan or
hyperreflective signals due to other pathologies. Our
findings indicate that hyperreflective signals increased
with disease activity, suggesting that SD-OCT may be
employed to monitor the progression of PIOL, which
may influence decision making in the management of
the disease.
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